Clinical Nutrition

ENTEREX® KIDZ

  • Nutritional Liquid Shake for Children
  • Lactose and Gluten Free
  • Over 25 Essential Nutrients per Serving
  • DHA Omega-3 (32 mg per 8-fl-oz serving) for Brain and Eye Health

Temporarily Out of Stock

ENTEREX® KIDZ

Specialized Nutritional Formula for Children®
Containing Prebiotics (FOS) and DHA

 

Enterex® Kidz is a complete and nutritionally balanced shake specially formulated for children. Each serving of Enterex® Kidz provides protein, carbohydrates, healthy fats, vitamins and minerals and may be consumed as a convenient snack or nutritional supplement.

  • DHA Omega-3 (32 mg per 8-fl-oz serving) for Brain and Eye Health
  • Taurine and Carnitine for Growth and Energy
  • Good Source of  Iron and Protein
  • With Prebiotics (FOS) for Digestive and Immune System Health
  • Calcium and Vitamin D for Strong Bones
  • Lactose Free and Gluten Free
  • Over 25 Essential Nutrients in Each Serving
  • Vanilla Flavor

Recommended by Doctors and Nutritionists

 

PRESENTATION: LIQUID

Catalog Number Units per Case Size Flavor
22000 24 single cans 8 oz Vanilla
22100 4 six-packs (24 cans total) 8 oz Vanilla
 
*This product cannot be sold or distributed in the State of Vermont.
 

NUTRITIONAL INFORMATION
Nutrients per serving (8 oz)


Calories (kcal) 240
Energy (kJ) 1004
Water (g) 200
Protein (g) 8
Total Fat (g) 12
Saturated Fat (g) 3
Trans Fat (g) 0
Cholesterol (mg) 6
Carbohydrate (g) 26
Sugar (g) 26
Fiber (g) 2
Vitamin A (IU) 610
Vitamin D (IU) 120
Vitamin E (IU) 5.4
Vitamin K (mcg) 9.0
Vitamin C (mg) 24
Vitamin B6 (mg) 0.62
Vitamin B12 (mcg) 1.4
Folic Acid (mcg) 88
Thiamine (mg) 0.64
Riboflavin (mg) 0.5
Niacin (mg) 4.0
Choline (mg) 71
Biotin (mcg) 76
Pantothenic Acid (mg) 2.4
Inositol (mg) 19
Sodium (mg) 90
Potassium (mg) 310
Chloride (mg) 240
Calcium (mg) 230
Phosphorus (mg) 190
Magnesium (mg) 47
Iodine (mcg) 23
Manganese (mg) 0.24
Copper (mg) 0.24
Zinc (mg) 2.8
Iron (mg) 3.3
Chromium (mcg) 7.1
Molybdenum (mcg) 8.5
Selenium (mcg) 5.4
DHA (mg) 32
L-Carnitine (mg) 10
Taurine (mg) 25

Ingredients: Water, sugar (sucrose), canola oil, maltodextrin (a source of dietary fiber), concentrated milk protein, MCT oil (Medium-Chain Triglycerides), concentrated whey protein. Less than 2% of: fructooligosaccharides (probiotics), tricalcium phosphate, natural and artificial flavors, sodium chloride, potassium dihydrogen phosphate, potassium citrate, magnesium chloride, phytonadione, potassium chloride, soy lecithin, emulsifier (monoglycerides and diglycerides of hydrogenated soybean oil. tocopherol, ascorbic acid and citric acid added as antioxidants), refined fish oil (tuna) (source of DHA), jellyfish (Tilapia), carrageenan, choline chloride, ascorbic acid, sodium ascorbate, M-inositol, vitamin E acetate, taurine, zinc sulfate, niacinamide, calcium pantothenate, ferrous sulfate, L-carnitine, vitamin A palmitate, vitamin D3, pyridoxine hydrochloride, thiamine mononitrate, riboflavin, manganese sulfate, copper sulfate, cyanocobalamin , magnesium oxide, folic acid, biotin, chromium chloride, potassium iodide, sodium molybdate, sodium selenite, potassium hydroxide. Contains milk and soy ingredients.

Caloric Density (kcal/mL) 1.0
Caloric Distribution
Protein (% kcal) 12.5
Carbohydrate (% kcal) 43.3
Fat (% kcal) 44.2
Total Cal/g N 200:1
Non-Protein Cal/g N 175:1
Kosher Yes
Gluten free Yes
Lactose free Yes

 

DIRECTIONS OF USE:

Serve cold.
Consume orally, do not administer via a feeding tube.
Refrigerate unused portion and consume within 24 hours.

 

PRECAUTIONS

This product is not intended for children under one year of age unless specified by a healthcare professional.
This product should not be used by children with Galactosemia.
NOT FOR PARENTERAL USE

FREQUENTLY ASKED QUESTIONS

 

We currently have no frequently asked questions for this product. If you have any questions please click here.

PEDIATRIC NUTRITION

  • Whitney EN, Rolfes SR. Life Cycle Nutrition: Infancy, Childhood, and Adolescence. Understanding Nutrition,7th Edition. 1996:577-609.
  • Lucas B. Nutrition in childhood. Krause’s Food, Nutrition, and Diet Therapy, 9th Edition. LK Mahan, S Escott-Stump, eds. WB Saunders Company, 1996:257-74.
  • Centers for Disease Control and Prevention. Pediatric nutrition surveillance, 1997 full report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1998.

 

OMEGA-3 FATTY ACIDS & DOCOSOHEXAENOIC ACID (DHA)

  • American Dietetic Association. Position of the American Dietetic Association and Dietitians of Canada: Fatty Acids. J Am Diet Assoc. 2007;107:1599-1611.
  • American Dietetic Association. Nutrition Fact Sheet: DHA: A Good Fat. 2008.
  • Arterburn LM, Hall EB, Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83(suppl):1467S-76.
  • Birch EE, Castañeda YS, Wheaton DH, Birch DG, Uauy RD, Hoffman DR. Visual maturation of term infants fed long-chain polyunsaturated fatty acid–supplemented or control formula for 12 mo. Am J Clin Nutr. 2005;81:871–9.
  • Carrero JJ, Martín-Bautista E, Barò L, Fonollá J, Jimé;nez J, Boza JJ, López-Huertas E. Efectos cardiovasculares de los ácidos grasos omega-3 y alternativas para incrementar su ingesta. Nutr Hosp. 2005;20(1): 63-9.
  • Engler MM, Engler MB, Arterburn LM, Bailey E, Chiu EY, Malloy MJ, Mietus-Snyder ML. Docosahexaenoic acid supplementation alters plasma phospholipid fatty acid compositionin hyperlipidemic children: results from the Endothelial Assessment of Risk from Lipids in Youth (EARLY) study. Nutr Res. 2004;24:721-29.
  • Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S, Stuehlinger M, Morrow J, Ridker P, Rifai N, Mietus-Snyder ML. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Therap. 2004;42:672-79.
  • Hoffman DR, Theuer RC, Castañeda YS, Wheaton DH, Bosworth RG, O’Connor AR, Morale SE, Wiedemann LE, Birch EE. Maturation of Visual Acuity is accelerated in Breast-Fed Term Infants Fed Baby Food Containing DHA-Enriched Egg Yolk. J Nutr. 2004;134:2307–13.
  • Kidd PM. Omega-3 DHA and EPA for Cognition, Behavior, and Mood: Clinical Findings and Structural-Functional Synergies with Cell Membrane Phospholipids. Alt Med Rev Volume 12, Number 3 2007;12(3):207-27
  • Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to developmentg and fuction of the brain and retina. Prog Lipid Res. 2001;40:1-94.
  • Madden SM, Garrioch CF, Holub BJ.Direct diet quantification indicates low intakes of (n-3) fatty acids in children 4 to 8 years old. J Nutr. 2009;139(3):528-32.
  • McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am J Clin Nutr. 2005;82:281–95.
  • Salem N, Litman B, Kim HY, Gawrisch K. Mechanisms of Action of Docosahexaenoic Acid in the Nervous System. Lipids. 2001(36):945–59.
  • Sanhueza J, Nieto S, Valenzuela A. Ácido  Docosohexaenoico (DHA), Desarrollo Cerebral, Memoria, y Aprendizaje: La Importancia de la Suplementación Perinatal. Rev Chil Nutr. 2004;31(2).
  • Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr. 2005;72(3):239-42.
  • Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE. Essential Fatty Acids in Visual and Brain Development. Lipids. 2001;36(9):885-95.
  • Valenzuela A, Nieto S. Ácidos grasos omega-6 y omega-3 en la nutrición perinatal: su importancia en el desarrollo del sistema nervioso y visual. Rev Chil Pediatr. 2003;74(2):149-57.

 

PREBIOTICS

  • Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early Dietary Intervention with a Mixture of Prebiotic Oligosaccharides Reduces the Incidence of Allergic Manifestations and Infections during the First Two Years of Life. J Nutr. 2008;138 1091–95.
  • Bouhnik Y, Raskine L, Simoneau G, Paineau D, Bornet F. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: a dose-response relationship study in healthy humans. Nutr J. 2006;5:8.
  • Tashiro Y, Oike H, Aramaki K, Hirayama M, Adachi T. In vitro ferementation of fructooligosaccharides in comparison with other oligo- and polysaccharides. Abstract, Wageningen, Netherlands. 1997.
  • Veerman G. Pediatric Applications of Inulin and Oligofructose. J Nutr. 2007;137:2585S–9S.

 

TAURINE

  • Heird WC. Taurine in neonatal nutrition – revisited. Arch Dis Child Fetal Neonatal Ed. 2004;89:F473–4.
  • Wharton BA, Morley R, Isaacs EB, Cole TJ, Lucas A. Low plasma taurine and later neurodevelopment. Arch Dis Child Fetal Neonatal Ed. 2004;89:F497–8.

 

CARNITINE

  • Crill C, Storm M, Christensen ML, Hankins CT, Jenkins MB, Helms RA. Carnitine supplementation in premature neonates: Effect on plasma and red blood cell total carnitine concentrations, nutrition parameters, and morbidity. Clin Nutr. 2006(25).
  • Melegh B, Kerner J, Sándor A, Vincellér M, Kispál G. Oral L-carnitine supplementation in low-birth-weight newborns: a study on neonates requiring combined parenteral and enteral nutrition. Acta Paediatr Hung. 1986;27(3):253-8.